Korean Journal of Psychosomatic Medicine (정신신체의학)

Korean Psychosomatic Society (한국정신신체의학회)
권호 표지
DOI QR코드

DOI QR Code

Physiological Predictors of Treatment Response to Biofeedback in Patients With Panic Disorder

  • Seongje Cho (Department of Psychiatry, Seoul National University Bundang Hospital) ;
  • In-Young Yoon (Department of Psychiatry, Seoul National University Bundang Hospital) ;
  • Ji Soo Kim (Department of Psychiatry, Seoul National University Bundang Hospital) ;
  • Minji Lee (Department of Psychiatry, Seoul National University Bundang Hospital) ;
  • Hye Youn Park (Department of Psychiatry, Seoul National University Bundang Hospital)
  • Received : 2023.05.01
  • Accepted : 2023.06.12
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Biofeedback is a useful non-pharmacological treatment for panic disorder (PD), but no studies have identified physiological markers related to the treatment response. This study investigated predictors of the treatment response for biofeedback in patients with PD. Methods : A retrospective study based on the electronic medical records of 372 adult patients with PD was performed. Patients received biofeedback treatment at least once, and physiological markers including heart rate, heart rate variability, respiratory rate, skin conductance, skin temperature, and electromyography were collected before the treatment began. The patients were classified as responders or non-responders based on the change in Clinical Global Impression-Severity (CGI-S) score. Results : The response rate to biofeedback treatment was 30.4%. Multivariable logistic regression analysis revealed that a higher CGI-S score at baseline and fewer benzodiazepine prescriptions were associated with a better response to biofeedback treatment. According to subgroup analyses, the baseline CGI-S score, dose of benzodiazepines, and skin conductance are candidate predictors of the response to biofeedback treatment in men, while only baseline disease severity was associated with the treatment response in women. Conclusions : The present results suggest that skin conductance may be target marker and predictor for biofeedback in male patients with PD.

Keywords

Acknowledgement

This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2020R1A2C1102105).

References

  1. Ziffra M. Panic disorder: a review of treatment options. Ann Clin Psychiatry 2021;33:124-133.  https://doi.org/10.12788/acp.0014
  2. Schoenberg PL, David AS. Biofeedback for psychiatric disorders: a systematic review. Appl Psychophysiol Biofeedback 2014;39:109-135.  https://doi.org/10.1007/s10484-014-9246-9
  3. Weerdmeester J, van Rooij MM, Engels RC, Granic I. An integrative model for the effectiveness of biofeedback interventions for anxiety regulation: viewpoint. J Med Internet Res 2020;22:e14958. 
  4. Prasko J, Latalova K, Diveky T, Grambal A, Kamaradova D, Velartova H, Salinger J, Opavsky J, Silhan P. Panic disorder, autonomic nervous system and dissociation-changes during therapy. Neuro Endocrinol Lett 2011;32:641-651. 
  5. Zhang Y, Zhou B, Qiu J, Zhang L, Zou Z. Heart rate variability changes in patients with panic disorder. J Affect Disord 2020;267:297-306.  https://doi.org/10.1016/j.jad.2020.01.132
  6. Beckham AJ, Greene TB, Meltzer-Brody S. A pilot study of heart rate variability biofeedback therapy in the treatment of perinatal depression on a specialized perinatal psychiatry inpatient unit. Arch Womens Ment Health 2013;16:59-65.  https://doi.org/10.1007/s00737-012-0318-7
  7. Walker JE, Lawson R. FP02 beta training for drug-resistant depression: a new protocol that usually reduces depression and keeps it reduced. J Neurother 2013;17:198-200.  https://doi.org/10.1080/10874208.2013.785784
  8. Reiner R. Integrating a portable biofeedback device into clinical practice for patients with anxiety disorders: results of a pilot study. Appl Psychophysiol Biofeedback 2008;33:55-61.  https://doi.org/10.1007/s10484-007-9046-6
  9. Siepmann M, Aykac V, Unterdorfer J, Petrowski K, Mueck-Weymann M. A pilot study on the effects of heart rate variability biofeedback in patients with depression and in healthy subjects. Appl Psychophysiol Biofeedback 2008;33:195-201.  https://doi.org/10.1007/s10484-008-9064-z
  10. Meuret AE, Wilhelm FH, Roth WT. Respiratory biofeedback-assisted therapy in panic disorder. Behav Modif 2001;25:584-605.  https://doi.org/10.1177/0145445501254006
  11. Kim S, Wollburg E, Roth WT. Opposing breathing therapies for panic disorder: a randomized controlled trial of lowering vs raising end-tidal PCO2. J Clin Psychiatry 2012;73:13479. 
  12. Herhaus B, Siepmann M, Kahaly GJ, Conrad R, Petrowski K. Effect of a biofeedback intervention on heart rate variability in individuals with panic disorder: a randomized controlled trial. Psychosom Med 2022;84:199-209.  https://doi.org/10.1097/PSY.0000000000001031
  13. Tolin DF, Billingsley AL, Hallion LS, Diefenbach GJ. Low pre-treatment end-tidal CO2 predicts dropout from cognitive-behavioral therapy for anxiety and related disorders. Behav Res Ther 2017;90:32-40.  https://doi.org/10.1016/j.brat.2016.12.005
  14. Lim JA, Lee YI, Jang JH, Choi SH. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder. Medicine (Baltimore) 2018;97:e12422. 
  15. Lim YJ, Yu BH, Kim JH. Korean panic disorder severity scale: construct validity by confirmatory factor analysis. Depress Anxiety 2007;24:95-102.  https://doi.org/10.1002/da.20206
  16. Park K, Jaekal E, Yoon S, Lee SH, Choi KH. Diagnostic utility and psychometric properties of the Beck Depression Inventory-II among Korean adults. Front Psychol 2019;10:2934. 
  17. Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 2015;180:179-184.  https://doi.org/10.1016/j.jad.2015.03.021
  18. Ashton CH. Benzodiazepines: how they work and how to withdraw. The Ashton manual 2002. 
  19. Kajantie E, Phillips DI. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006;31:151-178.  https://doi.org/10.1016/j.psyneuen.2005.07.002
  20. Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, Ray S, Money R, Saksa JR, Woods SW. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy. J Clin Psychiatry 2008;69:418-424.  https://doi.org/10.4088/JCP.v69n0312
  21. Khan A, Brodhead AE, Kolts RL, Brown WA. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res 2005;39:145-150.  https://doi.org/10.1016/j.jpsychires.2004.06.005
  22. Balon R, Starcevic V. Role of benzodiazepines in anxiety disorders. Adv Exp Med Biol 2020;1191:367-388.  https://doi.org/10.1007/978-981-32-9705-0_20
  23. Choi KW, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim DJ, Kim K, Yu HY, Jeon HJ. Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: a 12-week followup study. J Affect Disord 2019;246:157-165.  https://doi.org/10.1016/j.jad.2018.12.048
  24. Doberenz S, Roth WT, Wollburg E, Breuninger C, Kim S. Twenty-four hour skin conductance in panic disorder. J Psychiatr Res 2010;44:1137-1147.  https://doi.org/10.1016/j.jpsychires.2010.04.012
  25. Pineau G, Jean E, Romo L, Villemain F, Poupon D, Gorwood P. Skin conductance while facing emotional pictures at day 7 helps predicting antidepressant response at three months in patients with a major depressive episode. Psychiatry Res 2022;309:114401. 
  26. Fowles DC. Electrodermal hyporeactivity and antisocial behavior: does anxiety mediate the relationship? J Affect Disord 2000;61:177-189.  https://doi.org/10.1016/S0165-0327(00)00336-0
  27. Roth WT, Wilhelm FH, Trabert W. Autonomic instability during relaxation in panic disorder. Psychiatry Res 1998;80:155-164.  https://doi.org/10.1016/S0165-1781(98)00066-3
  28. Bari DS. Gender differences in tonic and phasic electrodermal activity components. Science Journal of University of Zakho 2020;8:29-33.  https://doi.org/10.25271/sjuoz.2020.8.1.670
  29. Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB. Is the course of panic disorder the same in women and men? Am J Psychiatry 1998;155:596-602.  https://doi.org/10.1176/ajp.155.5.596
  30. Grassi M, Caldirola D, Di Chiaro NV, Riva A, Dacco S, Pompili M, Perna G. Are respiratory abnormalities specific for panic disorder?: a meta-analysis. Neuropsychobiology 2014;70:52-60.  https://doi.org/10.1159/000364830
  31. Perera K, Pinto M, Kay R. Surface body temperature difference between anxious patients and non-anxious controls. IRCS Med Sci: Psychology & Psychiatry 1984;12:65-66. 
  32. Keough ME, Porter E, Kredlow MA, Worthington JJ, Hoge EA, Pollack MH, Shear MK, Simon NM. Anchoring the panic disorder severity scale. Assessment 2012;19:257-259.  https://doi.org/10.1177/1073191112436668
  33. Ryu HW, Koo MS, Yu BH. Effect of pharmacotherapy with paroxetine on biofeedback measurement variables in patients with panic disorder. Clin Psychopharmacol Neurosci 2004;2:36-40.